NK Cells to Induce Immunological Memory to Prevent HIV Infection (R01)
The summary for the NK Cells to Induce Immunological Memory to Prevent HIV Infection (R01) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
NK Cells to Induce Immunological Memory to Prevent HIV Infection (R01): The purpose of this Funding Opportunity Announcement (FOA) is to support multidisciplinary, hypothesis-driven research on Natural Killer (NK) cells, leading to the discovery of pathways relevant for early immune responses and immune regulation impacting the potential protective immunity to be induced by HIV vaccination.Secondary objectives include the development of novel technologies to allow for more definitive studies of human immune monitoring in the context of vaccine clinical trials and the recruitment of innate immunologists to the HIV vaccine field.
Federal Grant Title: | NK Cells to Induce Immunological Memory to Prevent HIV Infection (R01) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PA-14-217 |
Type of Funding: | Grant |
CFDA Numbers: | 93.855, 93.856 |
CFDA Descriptions: | Allergy, Immunology and Transplantation Research; Microbiology and Infectious Diseases Research |
Current Application Deadline: | Jan 7, 2017 |
Original Application Deadline: | Jan 7, 2017 |
Posted Date: | May 12, 2014 |
Creation Date: | May 12, 2014 |
Archive Date: | Feb 7, 2017 |
Total Program Funding: | |
Maximum Federal Grant Award: | none |
Minimum Federal Grant Award: | none |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Native American tribal organizations (other than Federally recognized tribal governments)
Independent school districts
Public and State controlled institutions of higher education
Private institutions of higher education
Public housing authorities/Indian housing authorities
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Small businesses
City or township governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal governments (Federally recognized)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Special district governments
State governments
For profit organizations other than small businesses - Additional Information on Eligibility
- Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. - Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/pa-files/PA-14-217.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
National Institutes of Health 301-496-3405 - Similar Government Grants
- • Tailoring HIV Curative Strategies to the Participant (UM1 Clinical Trial Not Allowed)
- • Center of Excellence for Systems Modeling of Infection and Immunity across Biological Scal...
- • NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
- • NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Tria...
- • Novel Approaches for Radiation Biodosimetry Assays and Devices Development (U01 Clinical T...
- • Center for HIV/AIDS Vaccine Immunology (CHAVI)
- • Genomics of Transplantation Cooperative Research Program
- • Asthma and Allergic Diseases Cooperative Research Centers
- More Grants from the National Institutes of Health
- • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
- • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
- • Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
- • AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
- • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)